Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1961 2
1962 2
1963 3
1964 2
1965 6
1966 7
1967 4
1968 6
1969 9
1970 6
1971 12
1972 5
1973 3
1974 4
1975 13
1976 8
1977 12
1978 8
1979 14
1980 15
1981 16
1982 20
1983 15
1984 21
1985 27
1986 34
1987 39
1988 32
1989 30
1990 18
1991 36
1992 33
1993 35
1994 31
1995 24
1996 31
1997 40
1998 37
1999 49
2000 56
2001 37
2002 50
2003 61
2004 68
2005 74
2006 63
2007 55
2008 78
2009 56
2010 77
2011 69
2012 99
2013 108
2014 117
2015 115
2016 129
2017 119
2018 132
2019 127
2020 168
2021 184
2022 191
2023 171
2024 160
2025 140

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,097 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant S-1 plus endocrine therapy for oestrogen receptor-positive, HER2-negative, primary breast cancer: a multicentre, open-label, randomised, controlled, phase 3 trial.
Toi M, Imoto S, Ishida T, Ito Y, Iwata H, Masuda N, Mukai H, Saji S, Shimizu A, Ikeda T, Haga H, Saeki T, Aogi K, Sugie T, Ueno T, Kinoshita T, Kai Y, Kitada M, Sato Y, Jimbo K, Sato N, Ishiguro H, Takada M, Ohashi Y, Ohno S. Toi M, et al. Among authors: shimizu a. Lancet Oncol. 2021 Jan;22(1):74-84. doi: 10.1016/S1470-2045(20)30534-9. Lancet Oncol. 2021. PMID: 33387497 Clinical Trial.
Renal Pathology Society/International Kidney and Monoclonal Gammopathy Research Group consensus on pathologic definitions and terminology of monoclonal gammopathy-associated kidney lesions.
Nasr SH, Royal V, Best Rocha A, Büttner-Herold M, Roufosse C, Bridoux F, Ismail W, Bu L, Cornell LD, Dendooven A, Gupta RK, Hara S, Javaugue V, Kozakowski N, Kudose S, Méndez GP, Oliver K, Picken MM, Santoriello D, Sethi S, Shimizu A, Singh G, Stokes MB, Wang SX, Leung N, Markowitz GS, D'Agati VD. Nasr SH, et al. Among authors: shimizu a. Kidney Int. 2025 Aug;108(2):184-193. doi: 10.1016/j.kint.2025.04.007. Epub 2025 Apr 23. Kidney Int. 2025. PMID: 40280412
Spatial proteo-transcriptomic profiling reveals the molecular landscape of borderline ovarian tumors and their invasive progression.
Schweizer L, Krishnan R, Shimizu A, Metousis A, Kenny H, Mendoza R, Nordmann TM, Rauch S, Kelliher L, Heide J, Rosenberger FA, Bilecz A, Borrego SN, Strauss MT, Thielert M, Rodriguez E, Müller-Reif JB, Chen M, Yamada SD, Mund A, Lastra RR, Mann M, Lengyel E. Schweizer L, et al. Among authors: shimizu a. medRxiv [Preprint]. 2023 Nov 13:2023.11.13.23298409. doi: 10.1101/2023.11.13.23298409. medRxiv. 2023. Update in: Cancer Cell. 2025 Aug 11;43(8):1495-1511.e7. doi: 10.1016/j.ccell.2025.06.004. PMID: 38014221 Free PMC article. Updated. Preprint.
Spatial proteo-transcriptomic profiling reveals the molecular landscape of borderline ovarian tumors and their invasive progression.
Schweizer L, Kenny HA, Krishnan R, Kelliher L, Bilecz AJ, Heide J, Donle L, Shimizu A, Metousis A, Mendoza R, Nordmann TM, Rauch S, Richter S, Li Y, Rosenberger FA, Strauss MT, Kurnit KC, Thielert M, Rodriguez E, Müller-Reif JB, Yamada SD, Theis FJ, Mund A, Lastra RR, Mann M, Lengyel E. Schweizer L, et al. Among authors: shimizu a. Cancer Cell. 2025 Aug 11;43(8):1495-1511.e7. doi: 10.1016/j.ccell.2025.06.004. Epub 2025 Jun 26. Cancer Cell. 2025. PMID: 40578359
KRAS Mutations in Duodenal Lavage Fluid after Secretin Stimulation for Detection of Pancreatic Cancer.
Yachida S, Yoshinaga S, Shiba S, Urabe M, Tanaka H, Takeda Y, Shimizu A, Sakamoto Y, Hijioka S, Haba S, Ashida R, Kushiyama Y, Asano K, Kobayashi M, Murawaki Y, Onishi K, Yamashita T, Kimura H, Totoki Y, Kamada H, Isomoto H, Hattori S, Morizane C, Ohkawa K, Kitano M, Hara K, Ikezawa K, Hanada K, Matsumoto K. Yachida S, et al. Among authors: shimizu a. Ann Surg. 2025 Feb 4. doi: 10.1097/SLA.0000000000006645. Online ahead of print. Ann Surg. 2025. PMID: 39902566
Genetic architecture of alcohol consumption identified by a genotype-stratified GWAS and impact on esophageal cancer risk in Japanese people.
Koyanagi YN, Nakatochi M, Namba S, Oze I, Charvat H, Narita A, Kawaguchi T, Ikezaki H, Hishida A, Hara M, Takezaki T, Koyama T, Nakamura Y, Suzuki S, Katsuura-Kamano S, Kuriki K, Nakamura Y, Takeuchi K, Hozawa A, Kinoshita K, Sutoh Y, Tanno K, Shimizu A, Ito H, Kasugai Y, Kawakatsu Y, Taniyama Y, Tajika M, Shimizu Y, Suzuki E, Hosono Y, Imoto I, Tabara Y, Takahashi M, Setoh K; BioBank Japan Project; Matsuda K, Nakano S, Goto A, Katagiri R, Yamaji T, Sawada N, Tsugane S, Wakai K, Yamamoto M, Sasaki M, Matsuda F, Okada Y, Iwasaki M, Brennan P, Matsuo K. Koyanagi YN, et al. Among authors: shimizu a. Sci Adv. 2024 Jan 26;10(4):eade2780. doi: 10.1126/sciadv.ade2780. Epub 2024 Jan 26. Sci Adv. 2024. PMID: 38277453 Free PMC article.
[Trichophyton tonsurans Infection].
Futatsuya T, Anzawa K, Mochizuki T, Shimizu A. Futatsuya T, et al. Among authors: shimizu a. Med Mycol J. 2023;64(3):49-54. doi: 10.3314/mmj.23-001. Med Mycol J. 2023. PMID: 37648498 Free article. Review. Japanese.
Inhibition of the chemokine signal regulator FROUNT by disulfiram ameliorates crescentic glomerulonephritis.
Toda E, Sawada A, Takeuchi K, Wakamatsu K, Ishikawa A, Kuwahara N, Sawa Y, Hatanaka S, Kokubo K, Makino K, Takahashi H, Endo Y, Kunugi S, Terasaki M, Terasaki Y, Matsushima K, Terashima Y, Shimizu A. Toda E, et al. Among authors: shimizu a. Kidney Int. 2022 Dec;102(6):1276-1290. doi: 10.1016/j.kint.2022.07.031. Epub 2022 Aug 30. Kidney Int. 2022. PMID: 36049642 Free article.
3,097 results